AstraZeneca COVID-19 shot candidate shows promise among elderly in trials

The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70 - who are at higher risk of serious illness and death from COVID-19 - could build robust immunity to the pandemic disease, researchers said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2IRXxYs
via IFTTT